In particular, PD-L1 blockade on melanoma and lung cancer cells inhibited glycolysis resulting in an increased availability of glucose in the TME and subsequently promoted anti-tumour T cell function (Kim et al. 2019). This evidence concerns the gene CD274 and lung carcinoma.